Dr. Mitchell on Colorectal Cancer Treatment Options

Video

In Partnership With:

Edith Mitchell, MD, FACP, clinical professor, director, Center to Eliminate Cancer Disparities Program Leader, Thomas Jefferson University, talks about the growing number of drugs and regimens for patients with colorectal cancer.

Edith Mitchell, MD, FACP, clinical professor, director, Center to Eliminate Cancer Disparities Program Leader, Thomas Jefferson University, talks about the growing number of drugs and regimens for patients with colorectal cancer.

Mitchell says the approval of aflibercept adds to the growing list of drugs for patients with colorectal cancer.

In 1996, Mitchell says, 5-gluorouracil was the only drug that showed benefit for patients with metastatic colorectal cancer. Now, as a variety of drugs are available to patients, doctors can strive for the best quality of life possible.

As the number of drugs has increased, so has the improvement of survival for patients with colorectal cancer, Mitchell says.

Related Videos
A panel of 6 experts on colorectal cancer
A panel of 6 experts on colorectal cancer
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD